Last reviewed · How we verify
A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)
The investigators plan to perform multi-omics technologies, including genomic, transcriptomic, epigenomic and proteomic methods, in patients with metastatic prostate cancer, aiming at uncovering the mechanism of the tumor progression, identifying distinct tumor subtypes and finding new treatment targets.
Details
| Lead sponsor | West China Hospital |
|---|---|
| Status | UNKNOWN |
| Enrolment | 100 |
| Start date | Sun Aug 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Apr 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Prostate Cancer Metastatic